Company Profile
Catalyst OrthoScience Inc. is a US-based manufacturer of shoulder arthroplasty systems, headquartered in Naples, Florida 34110, United States. Founded in 2014 by orthopedic surgeon Steven Goldberg, M.D., the company operates as an independent private entity, led by President and CEO Carl O'Connell, serving orthopedic surgeons, hospitals and ambulatory surgery centers across the United States. In 2026, the company celebrates the 10-year anniversary of the first Catalyst CSR clinical implantation.
Core Products ＆ Technologies
Anatomic Total Shoulder Systems
• Catalyst CSR™ Total Shoulder System: A stemless anatomic shoulder arthroplasty system featuring an ellipsoid humeral head and multiplanar osteotomy technique, FDA-cleared in 2016
• Archer CSR™ Total Shoulder System: The evolved single-tray anatomic system with precision elliptical humeral head and less invasive glenoid component for consistent joint line restoration
Reverse Shoulder ＆ Fracture Systems
• Archer R1™ Reverse Shoulder System: A single-tray reverse arthroplasty system offering surgeon-targeted implant positioning and bone-sparing implants, FDA 510(k) cleared in 2021
• Catalyst Fracture Shoulder System: A fracture-specific reverse and anatomic platform for proximal humeral fractures with dedicated tuberosity repair kits, fully released in August 2025 and granted expanded FDA indications in December 2025
Precision Planning ＆ Patient-Specific Technologies
• Archer® 3D Planning Software: A preoperative planning platform enabling personalized implant positioning for anatomic and reverse procedures
• Archer® Patient-Specific Instrumentation (PSI): A full suite of humeral and glenoid guides tailored to patient anatomy, FDA 510(k) cleared in February 2026, developed in partnership with 3D-Side
Proprietary Design Features
• Ellipsoid Humeral Head Design: Anatomically shaped implant replicating the native non-spherical humeral head for more natural kinematics
• Multiplanar Osteotomy Technique: A canal-sparing surgical approach minimizing bone removal while preserving the densest bone for fixation
• Single-Tray Portfolio: Streamlined instrument sets for anatomic, reverse and fracture procedures designed to reduce operative steps and processing demands
Market Position ＆ Certifications
Catalyst OrthoScience holds a differentiated position in the US shoulder arthroplasty market, competing with Zimmer Biomet, Stryker and DePuy Synthes. Key strengths include:
• 10+ years of US clinical heritage in stemless shoulder replacement innovation
• Bone preservation: CSR system designed to spare significantly more bone than traditional stemmed designs
• Clinical outcomes: 5-8 year data showing 77% of patients with SANE score ≥ 95, low revision rates and early functional recovery
• Regulatory compliance: FDA-cleared for anatomic total shoulder, reverse shoulder and fracture applications
• Intellectual property: Growing portfolio of granted and pending US and international patents
Corporate Timeline
2014 — Founded by orthopedic surgeon Steven Goldberg, M.D. in Naples, Florida
2016 — FDA clearance for the Catalyst CSR Total Shoulder System
2019 — Closes $12.7 million oversubscribed Series C-1 financing led by River Cities Capital Funds
2021 — FDA 510(k) clearance for the Archer R1 Reverse Shoulder System
2025 — Publishes 5-8 year midterm clinical data for CSR; full commercial release of the Catalyst Fracture Shoulder System
2025 — FDA 510(k) clearance for expanded fracture system indications including anatomic procedures
2026 — FDA 510(k) clearance for Archer Patient-Specific Instrumentation; single-tray portfolio expanded to include fracture system
2026 — Catalyst Fracture System wins Medical Device Engineering Breakthrough award at MedTech Breakthrough Awards
2026 — Celebrates 10 years since first Catalyst CSR clinical implantation
Target Markets ＆ Applications
• Anatomic Total Shoulder Arthroplasty: CSR and Archer CSR systems for primary osteoarthritis and rotator cuff-intact patients in hospital and ASC settings
• Reverse Shoulder Arthroplasty: Archer R1 system for rotator cuff-deficient patients requiring reverse reconstruction
• Proximal Humeral Fractures: Fracture Shoulder System for complex trauma cases requiring tuberosity fixation and healing optimization
• Revision-Ready Preservation: Bone-sparing stemless designs enabling simplified future revision procedures
Contact Information
Global Headquarters
Address: Naples, Florida 34110, United States
Corporate Online Presence
Website: catalystortho.com
Social: LinkedIn
